IT

Gartner

$205.35

-0.95%
Oct 16, 2026
Bobby Quantitative Model
Gartner, Inc. is a research and advisory firm that supplies independent analysis on information technology to CIOs and other enterprise decision-makers, best known for its flagship Magic Quadrant reports that heavily influence corporate IT procurement; roughly 80% of revenue comes from subscription research, with the remainder split between consulting engagements and some of the largest conferences in the IT industry. The company occupies a distinctive position as a quasi-utility of enterprise technology decision-making — a high-margin, subscription-heavy franchise with entrenched customer relationships rather than a product or platform competitor. The current investor debate centers on whether generative AI is a structural threat to Gartner's research model or a demand tailwind, a question that drove a violent sentiment swing in 2026: the stock collapsed through the spring and early summer on AI-disruption fears, then surged after a strong Q2 earnings beat and raised guidance in early August that management and bulls framed as evidence the disruption narrative is overblown. More recently, Gartner's own public warnings about neocloud overcapacity and debt-fueled AI infrastructure buildouts have kept the firm in the headlines, reinforcing its role as an influential — and occasionally market-moving — voice on enterprise technology spending.

People also watch

IBM

IBM

IBM

Analysis
Accenture

Accenture

ACN

Analysis
Cognizant Technology Solutions

Cognizant Technology Solutions

CTSH

Analysis
Fiserv

Fiserv

FISV

Analysis
Broadridge Financial Solutions

Broadridge Financial Solutions

BR

Analysis

IT 12-Month Price Forecast

Historical Price
Current Price $205.35
Average Target $205.35
High Target $236.15
Low Target $174.55

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Gartner's 12-month outlook, with a consensus price target around $189.54 and implied upside of -7.7% versus the current price.

Average Target

$189.54

0 analysts

Implied Upside

-7.7%

vs. current price

Analyst Count

—

covering this stock

Price Range

$150 - $229

Analyst target range

Coverage is moderate, with 13 analysts and a consensus recommendation of "hold" (mean rating 2.8 on a scale where 1 is strong buy and 5 is strong sell). The average target price of $189.54 sits below the current price of $205.35, implying roughly 7.7% downside to consensus — an unusual setup where the stock has rallied past the Street's average fair value, suggesting analysts have been slow to revise models after the August guidance raise. Sentiment leans neutral-to-cautious rather than bullish, consistent with the hold rating and the fact that the stock's 46% three-month rally has outrun published targets. The target range is wide, from a low of $150.00 to a high of $229.00 — a spread of about 53% of the low end — signaling genuine disagreement about the AI-disruption question. The high target of $229 assumes the Q2 guidance raise is the start of a re-acceleration cycle, with research renewals stabilizing, events and consulting growing, and multiple expansion back toward historical norms; the low target of $150 prices in continued revenue contraction and margin pressure as AI tools erode the value of syndicated research. Institutional ratings show a firmly entrenched cautious stance — BMO (Market Perform), UBS (Neutral), Wells Fargo (Underweight), Goldman Sachs (Neutral), RBC (Sector Perform), and Morgan Stanley (Equal Weight) have all reiterated without upgrades through 2026 — meaning the post-earnings rally has not been validated by rating changes, and the stock's move above consensus targets creates asymmetric risk if upcoming quarters fail to confirm the turnaround.

Drowning in data?

Find the real signal!

Bulls vs Bears: IT Investment Factors

The bull case currently has the stronger near-term evidence: margins are expanding (70.9% gross, 22.6% operating), free cash flow is $1.289 billion, and the stock trades at 2.80x sales versus 10.4x at end-2025 — a valuation that already discounts a lot of bad news. The bear case rests on a single but powerful fact: revenue is shrinking (-0.62% YoY) and the market has not yet proven whether that is a trough or structural decline. The most important tension in this debate is whether generative AI is a demand tailwind or a commoditization threat to Gartner's syndicated research — the Q2 guidance raise is evidence for the former, but the stock's rally past the $189.54 consensus target and the entrenched "hold" consensus mean the market has already priced in a fair amount of the optimistic resolution. With a beta of 0.978, the risk here is idiosyncratic event risk around quarterly prints rather than broad market exposure.

Bullish

  • Deep value on sales multiples: At a PS of 2.80x and EV/sales of 2.31x, Gartner trades at a fraction of its own history — PS was 21.9x at end-2024 and 10.4x at year-end 2025. For a business still generating a 70.9% Q2 gross margin and 25.2% EBITDA margin, that compression looks extreme if revenue merely stabilizes.
  • Forward PE gap implies re-rating: Trailing PE of 26.06x versus forward PE of 12.53x is an unusually wide spread, reflecting depressed trailing earnings (Q3 2025 EPS was just $0.47). If consensus 2027 EPS of ~$37.58 is even partially achieved, the current price embeds significant multiple expansion potential.
  • Cash generation remains elite: Trailing free cash flow is $1.289 billion against a market cap of roughly $18.2 billion, and Q2 2026 FCF was $378.4 million on $398.3 million of operating cash flow. The company holds $1.489 billion in cash and funded $547.1 million of Q2 buybacks internally.
  • Margins expanding despite flat revenue: Q2 2026 gross margin rose to 70.9% from 68.5% a year earlier, and operating margin improved to 22.6% from 19.4%, as SG&A of $764.6 million was held in check. Cost discipline is protecting profitability even with revenue down 0.62% YoY.

Bearish

  • Revenue growth has turned negative: Q2 2026 revenue of $1.676 billion fell 0.62% YoY, following Q1 2026 revenue of $1.511 billion versus $1.534 billion a year earlier. The core research subscription (~80% of revenue) is under renewal pressure, and Events ($244.2M) and Consulting ($141.9M) are too small to offset it.
  • Price has overshot analyst targets: The $205.35 price sits above the $189.54 consensus average target, implying roughly 7.7% downside, and the consensus rating is only "hold" (2.8 mean). Six major houses — BMO, UBS, Wells Fargo, Goldman, RBC, Morgan Stanley — have reiterated neutral-to-underweight without upgrades through 2026.
  • Leveraged buyback shrinks the cushion: A debt-to-equity ratio of 11.31 and a current ratio of 0.999 reflect an aggressive capital-return program ($547.1M of buybacks in Q2 alone) that has shrunk equity and pushed ROE to an optically extreme 227.9%. Less equity cushion means less flexibility if the subscription base deteriorates further.
  • AI disruption is unresolved: The entire spring collapse — a 52.39% maximum drawdown to $124.25 — was driven by fears that generative AI commoditizes syndicated research. The Q2 beat argues the fear is overblown but does not prove it; the analyst target range of $150 to $229 (a 53% spread) shows the Street genuinely disagrees.

IT Technical Analysis

Gartner is in a recovery uptrend within a longer-term downtrend: the stock is down 13.05% over the past year and 13.37% year-to-date, yet the current price of $205.35 sits roughly 65% of the way through a 52-week range of $124.25 to $261.10, meaning it has clawed back most of the ground lost during the spring collapse but remains well below its highs. The 52.39% maximum drawdown underscores how severe the earlier selloff was, and the current positioning implies the stock is neither an overextended momentum name nor a falling knife — it is a recovering laggard that has reclaimed significant territory but still has a long way to go to repair the annual trend. Short-term momentum is decisively positive and sharply divergent from the 1-year picture: the stock is up 46.48% over three months, 32.81% over six months, and 7.19% over the past month, versus a 1-year decline of 13.05%. That divergence reflects a violent mean-reversion rally off the June lows near $125 rather than a continuation of the prior downtrend, and relative strength confirms the acceleration — the stock has outperformed SPY by 43.79 percentage points over three months and 5.97 points over the past month, though it still lags the index by 28.58 points over a full year. The move has been punctuated by gap-like sessions (for example, the jump from $151.53 on August 3 to $185.79 on August 4), a hallmark of event-driven re-rating rather than steady accumulation, which raises the risk of sharp retracements. Key technical levels are the 52-week high of $261.10 as major resistance and the 52-week low of $124.25 as the critical support floor, with the recent breakout above the $200 round number now acting as near-term support; a sustained break above $207–$210 would open the path toward the mid-$220s and eventually the old high, while a failure back below $185 would signal the August gap is being filled and put the $170 area in play. With a beta of 0.978, Gartner's volatility is roughly in line with the market — slightly less than SPY — which is notable given the stock's 52% peak-to-trough drawdown and suggests the risk here is idiosyncratic (AI narrative and earnings surprises) rather than systematic, so position sizing should account for event risk around quarterly reports rather than broad market swings.

Beta

0.98

0.98x market volatility

Max Drawdown

-52.4%

Largest decline past year

52-Week Range

$124-$261

Price range past year

Annual Return

-13.1%

Cumulative gain past year

PeriodIT ReturnS&P 500
1m+7.2%+0.2%
3m+46.5%+2.9%
6m+32.8%+8.4%
1y-13.1%+14.9%
ytd-13.4%+11.9%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

IT Fundamental Analysis

Revenue growth has stalled: Q2 2026 revenue of $1.676 billion was down 0.62% year-over-year against $1.686 billion in Q2 2025, following Q1 2026 revenue of $1.511 billion (versus $1.534 billion a year earlier) and Q4 2025 revenue of $1.753 billion (versus $1.715 billion). The multi-quarter trend is one of decelerating to slightly negative growth, with the research subscription core facing renewal pressure while the smaller Events segment ($244.2 million) and Consulting segment ($141.9 million) provide diversification but not enough scale to offset the core. The Q2 print nonetheless beat expectations and prompted raised guidance, which is why the stock re-rated — the investment case now hinges on whether flat-to-down revenue is a trough or the start of a structural decline as AI tools commoditize the research product. Profitability remains robust despite the top-line stall: Q2 2026 net income was $275.5 million (16.4% net margin) on gross profit of $1.189 billion, a 70.9% gross margin, with operating income of $379.3 million (22.6% operating margin) and EBITDA of $422.1 million (25.2% margin). Margins have actually expanded year-over-year — Q2 2025 gross margin was 68.5% and operating margin 19.4% — as cost discipline (SG&A of $764.6 million) offset revenue softness, and the 67.7% trailing gross margin and 15.8% operating margin remain characteristic of a high-quality information-services franchise. The balance sheet and cash generation are the strongest part of the story: trailing free cash flow is $1.289 billion, Q2 2026 free cash flow was $378.4 million on operating cash flow of $398.3 million, and the company held $1.489 billion in cash at quarter-end. However, the debt-to-equity ratio of 11.31 reflects an aggressive capital-return program — $547.1 million of buybacks in Q2 alone and $534.6 million in Q1 — that has shrunk the equity base and pushed ROE to an optically extreme 227.9%; the current ratio of 0.999 is thin, and the 6.58 short ratio indicates meaningful bearish positioning. The company funds growth and buybacks internally from strong FCF, but the leveraged buyback strategy leaves less cushion if the subscription base deteriorates further.

Quarterly Revenue

$1.7B

2026-06

Revenue YoY Growth

-0.6%

YoY Comparison

Gross Margin

71.0%

Latest Quarter

Free Cash Flow

$1.3B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Events
Consulting

Open an Account, get $2 TSLA now!

Valuation Analysis: Is IT Overvalued?

Because Gartner is solidly profitable — Q2 2026 net income of $275.5 million and trailing EPS positive — the PE ratio is the appropriate primary metric. The trailing PE is 26.06x versus a forward PE of just 12.53x, an unusually wide gap that implies the market expects earnings to roughly double; this is partly an artifact of depressed trailing earnings (the Q3 2025 quarter showed EPS of only $0.47) and partly reflects consensus 2027 EPS estimates of about $37.58, which look aggressive relative to the current run-rate of roughly $14–$16 annualized. The 2.80x price-to-sales ratio and 2.31x EV/sales are low in absolute terms for a 70% gross-margin subscription business, while EV/EBITDA of 16.32x is moderate. Against the broader information-technology services sector, Gartner screens as a clear value outlier: a PS of 2.80x and EV/sales of 2.31x are far below the double-digit sales multiples the stock itself commanded as recently as 2024–2025 (historical PS ratios of 18–26x in 2024 and 10.4x at year-end 2025), and the 26x trailing PE is below the premium multiples typically awarded to high-margin research and data franchises. The discount appears justified by negative revenue growth (-0.62% YoY) and genuine AI-disruption uncertainty, but if the Q2 guidance raise marks a trough, the gap between 26x trailing and 12.5x forward PE suggests substantial re-rating potential. Historically, Gartner's valuation has compressed dramatically: the PS ratio has fallen from 21.9x at the end of 2024 to 10.4x at year-end 2025 to 2.80x now, and the PE has fallen from 23.6x (Q4 2024) to 18.8x (Q4 2025) to 26.1x trailing today on depressed earnings. The stock is near the bottom of its own multi-year valuation band on sales-based measures, which either signals a deep value opportunity if fundamentals stabilize or reflects the market pricing in structural deterioration of the research business — the 56.8x price-to-book ratio is distorted by the buyback-shrunken equity base and is not a useful anchor.

PE

26.1x

Latest Quarter

vs. Historical

Mid-Range

5-Year PE Range 8x~44x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

16.3x

Enterprise Value Multiple

Investment Risk Disclosure

Financial and operational risks center on the revenue trajectory and the balance-sheet structure. Q2 2026 revenue declined 0.62% YoY to $1.676 billion, and the core research subscription — roughly 80% of the business — faces renewal pressure that the smaller Events ($244.2M) and Consulting ($141.9M) segments cannot offset. The debt-to-equity ratio of 11.31 and current ratio of 0.999 reflect a capital-return program ($547.1M of buybacks in Q2, $534.6M in Q1) that has shrunk the equity base and pushed ROE to 227.9%, leaving less cushion if the subscription base deteriorates. Earnings volatility is real: Q3 2025 EPS was just $0.47 versus $4.14 in Q2 2026, so quarterly comparisons can swing violently and the 26.06x trailing PE is calculated on a depressed base.

Market and competitive risks are dominated by the AI-disruption question and valuation compression. The stock's 52.39% maximum drawdown to $124.25 was driven by fears that generative AI tools commoditize syndicated research, and the analyst target range of $150 to $229 (a 53% spread) shows the Street has no consensus on how that resolves. The stock has already rallied 46.48% in three months and now trades above the $189.54 consensus target, so the margin of safety has narrowed; six major houses remain neutral-to-underweight without upgrades. With a beta of 0.978, systematic market risk is modest — the real exposure is sector rotation away from information services and headline risk from Gartner's own public warnings on neocloud overcapacity and debt-fueled AI infrastructure, which keep the firm in the news but also tie its brand to the AI capex cycle.

Worst-case scenario: AI tools erode the value of syndicated research faster than Gartner can reposition, renewal rates slip, and the next quarterly print misses the raised guidance, forcing analysts to cut targets and the market to re-test the June lows. From the current $205.35, a retracement to the 52-week low of $124.25 would be a loss of roughly 39.5%, and the analyst low target of $150.00 implies about 27% downside. A more moderate adverse case — filling the August gap back toward $170 — represents roughly 17% downside. The 52.39% maximum drawdown is the historical precedent for how far this stock can fall when the AI narrative turns against it.